COVID-19’s global pandemic has led to an unprecedented worldwide situation. With a growing number of affected people and many countries either under lockdown or taking restrictive measures, our hopes lie in the finding a vaccine against the virus in record time.
From ClarkeModet’s Technological Intelligence area we have analyzed the trend on patent applications related to vaccines against three previous pandemics: the SARS and MERS coronaviruses and the Ebola virus. We have also analyzed how some organizations have used their previous know-how to speed up their SARS-CoV-2 vaccine candidate’s access to clinical trials.
Our aim is to analyse the industry’s response to similar challenges using patents as both an indicator and a thermometer of the intensity of R&D activity in response to these healthcare threats. Patents are the result of a research and development process that has generated innovative and sufficiently inventive results, making them a reliable indicator of the industry’s response capacity.
Moreover, the use of technological intelligence systems applied to the patent’s field, enables us to accelerate the vaccine development process, by means of locating available technology, avoiding research redundancies and identifying the strategies that were more successful when tackling the problem.
Our report includes:
From ClarkeModet, we can help you to identify and prospect trends and previous research lines in order to make progress in projects related to SARS-CoV-2 or COVID-19, as well as to identify the best partners.